EN
HI

Biocon Share price

BIOCON

397.3

0.85 (-0.21%)
NSE
BSE
Last updated on 30 Jul, 2025 | 15:40 IST
BUYSELL
Today's High

403.00

Today's Low

394.40

52 Week Low

291.00

52 Week High

406.00

The current prices are delayed, login to your account for live prices

Biocon Chart

Biocon Share Key Metrics

Volume
61.33 L
Market Cap
53117.57 CR
LTQ@LTP
50@397.30
ATP
398.92
Var Margin
17.3 %
Circuit Range
358.35-437.95
Delivery %
59.44 %
Value
244.67 CR
ASM/GSM
No
Market Lot
1

Biocon Futures & Options

BIOCON-EQ

397.3

-0.85 (-0.21%)

Biocon Option Chain

View Price, OI, Greeks & More...
View All

31JUL25

395.30

-3.15 (0.79%)

28AUG25

398.20

-2.20 (0.55%)

30SEP25

400.75

-1.60 (0.40%)

BIOCON|31JUL25 CE 395.00

3.60

-2.05 (-36.28%)

BIOCON|31JUL25 PE 400.00

5.1

0.3 (6.25%)

Biocon Corporate Actions

DateAgenda
2025-08-07Quarterly Results
2025-05-08Audited Results & Final Dividend
2025-04-23Others
2025-04-04To consider Fund Raising
2025-01-30Quarterly Results & Others
DateRecord Date
No Data Found

Biocon News

Not anticipating any immediate impact on our business due to US election result: Biocon CEO

Nov 08 2024 14:46:54

Biocon Biologics' Bengaluru unit classified as voluntary action indicated by USFDA

Oct 30 2024 17:56:58

Biocon shares slump 5.5% as net profit takes a dive in Q2

Oct 31 2024 10:06:54

Wipro, Biocon , IRB Infrastructure Developers , Larsen & Toubro, Tata Power Company In Focus

Oct 31 2024 10:21:57
Read More

About Biocon

NSE : 11373  
BSE : 532523  
ISIN : INE376G01013  

HISTORY AND CERTAIN CORPORATE MATTERSOur Company was incorporated as Biocon India Private Limited onNovember 29 1978 under the Companies Act. The word `Private' wasdeleted from our name under the provisions of Section 43A(2) of theCompanies Act with effect from July 1 1995. Thereafter our Company wasconverted to a private limited company under the provisions of Section43(2A) of the Companies Act with effect from December 21 2000. It wasreconverted into a public limited company on June 18 2001. The name ofour Company was changed from Biocon India Limited to Biocon Limited anda fresh certificate of incorporation consequent on change of name wasissued by the RoC on November 19 2003.Our Corporate StructureOur existing corporate structure is as under:Biocon LimitedClinigene International PrivateLimited (100.00%)Biocon Biopharmaceuticals PrivateLimited (51.00%)Syngene International PrivateLimited (99.99%)Interest of Promoters Directors and Key Managerial PersonnelExcept as stated in ?Related Party Transactions? on page 84 of this RedHerring Prospectus and to the extent of shareholding in our Companythe Promoters do not have any other interest in our business.Our Promoters have significant rights in our Company under the terms ofour Articles of Association. For additional information please referto the section entitled ?Main Provisions of Articles of Association ofBiocon Limited? on page 168 of this Red Herring Prospectus.Except to the extent of their compensation and to the extent of ESOPif any as mentioned on page 165 of this Red Herring Prospectus andtheir shareholding or shareholding of companies they represent theDirectors other than Promoter Directors do not have any otherinterest in our Company. Our Director Mr. John Shaw is the husband ofour Chairman & Managing Director Ms. Kiran Mazumdar-Shaw. OurDirector Prof. Ravi Mazumdar is the brother of our Chairman & ManagingDirector Ms. Kiran Mazumdar-Shaw. Our alternate Director Prof.Catherine Rosenberg is the sister-in-law of our Chairman & ManagingDirector Ms. Kiran Mazumdar-Shaw.The key managerial personnel of our Company do not have any interest inour Company other than to the extent of the remuneration or benefits towhich they are entitled to as per their terms of appointment andreimbursement of expenses incurred by them during the ordinary courseof business and to the extent of the Equity Shares held by them in theCompany if any and options granted to them under the ESOP.

Biocon Management

NamePosition
Ms. Kiran Mazumdar Shaw Executive Chairperson
Mr. Siddharth Mittal Managing Director & CEO
Prof. Ravi Rasendra Mazumdar Non Exe.Non Ind.Director
Mr. Eric Vivek Mazumdar Non Exe.Non Ind.Director
Mr. Bobby Kanubhai Parikh Independent Director
Read More

Biocon FAQs

The Buying Price of Biocon share is 397.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Biocon stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Biocon, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Biocon shares is 52.55. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Biocon shares is 2.07. Useful to assess the stock's value relative to its book value.

To assess Biocon’s valuation compare Sector P/E, P/B which are 35.89 & 3.9 with sector averages, along with growth rates and financial metrics.

The Market Cap of Biocon is 53117.57 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Biocon share price is 406.00 & 291.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.